COFCO Capital Holdings Co., Ltd. (002423.SZ)
CNY 12.68
(0.96%)
CNY 12.68
(0.96%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 100.41 Million CNY | 15.61% |
| 2022 | 86.85 Million CNY | -66.41% |
| 2021 | 258.58 Million CNY | -25.62% |
| 2020 | 347.66 Million CNY | 113.75% |
| 2019 | -2.52 Billion CNY | -685.73% |
| 2018 | 431.54 Million CNY | 26.77% |
| 2017 | 340.41 Million CNY | -16.99% |
| 2016 | 410.06 Million CNY | 18.26% |
| 2015 | 346.74 Million CNY | -12.86% |
| 2014 | 397.91 Million CNY | 5.83% |
| 2013 | 375.97 Million CNY | -3.65% |
| 2012 | 390.21 Million CNY | -11.25% |
| 2011 | 439.67 Million CNY | 18.05% |
| 2010 | 372.44 Million CNY | 39.55% |
| 2009 | 266.9 Million CNY | -40.63% |
| 2008 | 449.54 Million CNY | 15.39% |
| 2007 | 389.59 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 86.34 Million CNY | -14.01% |
| 2024 Q2 | 200.72 Million CNY | 132.48% |
| 2024 Q3 | 143.81 Million CNY | -28.35% |
| 2023 Q2 | 253.5 Million CNY | -16.67% |
| 2023 Q3 | 44.17 Million CNY | -82.58% |
| 2023 FY | 100.41 Million CNY | 15.61% |
| 2023 Q4 | 100.41 Million CNY | 127.33% |
| 2023 Q1 | 304.23 Million CNY | 250.28% |
| 2022 Q3 | 165.82 Million CNY | -49.72% |
| 2022 FY | 86.85 Million CNY | -66.41% |
| 2022 Q4 | 86.85 Million CNY | -47.62% |
| 2022 Q2 | 329.79 Million CNY | -8.52% |
| 2022 Q1 | 360.5 Million CNY | 39.41% |
| 2021 FY | 258.58 Million CNY | -25.62% |
| 2021 Q3 | 232.46 Million CNY | 102.15% |
| 2021 Q1 | 49.95 Million CNY | 0.0% |
| 2021 Q4 | 258.58 Million CNY | 11.24% |
| 2021 Q2 | -10.8 Billion CNY | -21721.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 FY | 347.66 Million CNY | 113.75% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2019 FY | -2.52 Billion CNY | -685.73% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2018 Q4 | 431.54 Million CNY | -0.02% |
| 2018 Q1 | 404.78 Million CNY | 18.91% |
| 2018 FY | 431.54 Million CNY | 26.77% |
| 2018 Q3 | 431.65 Million CNY | 4.94% |
| 2018 Q2 | 411.34 Million CNY | 1.62% |
| 2017 Q2 | 465.15 Million CNY | -6.66% |
| 2017 Q3 | 416.25 Million CNY | -10.51% |
| 2017 Q4 | 340.41 Million CNY | -18.22% |
| 2017 Q1 | 498.33 Million CNY | 21.53% |
| 2017 FY | 340.41 Million CNY | -16.99% |
| 2016 Q4 | 410.06 Million CNY | 10.88% |
| 2016 FY | 410.06 Million CNY | 18.26% |
| 2016 Q2 | 371.36 Million CNY | 4.82% |
| 2016 Q3 | 369.81 Million CNY | -0.42% |
| 2016 Q1 | 354.29 Million CNY | 2.18% |
| 2015 Q2 | 398.45 Million CNY | -4.59% |
| 2015 FY | 346.74 Million CNY | -12.86% |
| 2015 Q4 | 346.74 Million CNY | -13.49% |
| 2015 Q3 | 400.79 Million CNY | 0.59% |
| 2015 Q1 | 417.63 Million CNY | 4.96% |
| 2014 Q2 | 442.57 Million CNY | 1.93% |
| 2014 Q4 | 397.91 Million CNY | -10.42% |
| 2014 FY | 397.91 Million CNY | 5.83% |
| 2014 Q1 | 434.17 Million CNY | 15.48% |
| 2014 Q3 | 444.17 Million CNY | 0.36% |
| 2013 Q2 | 421.65 Million CNY | 6.17% |
| 2013 Q1 | 397.16 Million CNY | 1.78% |
| 2013 Q4 | 375.97 Million CNY | -9.21% |
| 2013 FY | 375.97 Million CNY | -3.65% |
| 2013 Q3 | 414.1 Million CNY | -1.79% |
| 2012 Q1 | 422.05 Million CNY | -4.01% |
| 2012 Q2 | 495.43 Million CNY | 17.39% |
| 2012 Q3 | 432.74 Million CNY | -12.65% |
| 2012 Q4 | 390.21 Million CNY | -9.83% |
| 2012 FY | 390.21 Million CNY | -11.25% |
| 2011 Q1 | 414.25 Million CNY | 11.22% |
| 2011 FY | 439.67 Million CNY | 18.05% |
| 2011 Q4 | 439.67 Million CNY | 3.64% |
| 2011 Q3 | 424.23 Million CNY | 0.0% |
| 2011 Q2 | 424.22 Million CNY | 2.41% |
| 2010 FY | 372.44 Million CNY | 39.55% |
| 2010 Q1 | 300.18 Million CNY | 12.47% |
| 2010 Q3 | 353.14 Million CNY | 11.14% |
| 2010 Q4 | 372.44 Million CNY | 5.47% |
| 2010 Q2 | 317.75 Million CNY | 5.85% |
| 2009 Q4 | 266.9 Million CNY | 0.0% |
| 2009 FY | 266.9 Million CNY | -40.63% |
| 2008 FY | 449.54 Million CNY | 15.39% |
| 2007 FY | 389.59 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Hubei Biocause Pharmaceutical Co., Ltd. | 4.13 Billion CNY | 97.57% |